Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M

Aug. 04, 2022 7:39 AM ETSotera Health Company (SHC)By: Shweta Agarwal, SA News Editor
  • Sotera Health press release (NASDAQ:SHC): Q2 GAAP EPS of $0.11 misses by $0.05.
  • Revenue of $266.64M (+5.8% Y/Y) beats by $10.34M.
  • Adjusted EBITDA for the second-quarter 2022 increased 1.2% over the second quarter of 2021 to $136M.
  • FY 2022 Guidance: Net revenues in the range of $1.0 to $1.022 billion, from previous guidance of $1.0 to $1.03 billion, representing growth of approximately 7% to 10%, compared to the prior year, vs. consensus of $1.02B
  • Adjusted EBITDA in the range of $515 to $525 million, from previous guidance of $515 to $535 million, representing growth of approximately 7% to 9%, compared to the prior year
  • Adjusted EPS in the range of $0.93 to $0.97 from previous guidance of $0.93 to $0.99 representing growth of 6% to 10% versus the prior year, vs. consensus of $0.96.
  • Capital expenditures in the range of $140 million to $170 million

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.